Divi's Laboratories Limited

DIVISLAB

INE361B01024

Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.

Sector

Pharmaceuticals

Calendar

2024-08-01 - Détachement de for final dividend

Related indices

NIFTY 50 , NIFTY 100

More about the company

Income Statement Evolution

More financial data

Ratings for Divi's Laboratories Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

4,539 INR

Average target price

3,895 INR

Spread / Average Target

-14.19%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
DIVI'S LABORATORIES LIMITED	+16.28%	14.43B
ELI LILLY AND COMPANY	+62.66%	854B
NOVO NORDISK A/S	+40.42%	636B
JOHNSON & JOHNSON	-4.37%	361B
MERCK & CO., INC.	+17.16%	324B
ABBVIE INC.	+9.87%	301B
ASTRAZENECA PLC	+15.66%	247B
ROCHE HOLDING AG	+4.21%	230B
NOVARTIS AG	+17.90%	228B
AMGEN INC.	+14.86%	177B

Other Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 07:43:53 2024-07-12 am EDT			5-day change	1st Jan Change
4,539 ^INR	-0.94%		-1.95%	+16.28%

Jul. 12	IT Stocks Rally Push Indian Equities to Close Higher on Friday	MT
Jul. 10	Indian Shares Dragged Down by Auto, Metal and Bank Stocks	MT

IT Stocks Rally Push Indian Equities to Close Higher on Friday	Jul. 12	MT
Indian Shares Dragged Down by Auto, Metal and Bank Stocks	Jul. 10	MT
Indian Equities Close Flat on Monday Amid Absence of New Market Triggers	Jul. 08	MT
Divi's Laboratories Limited Announces Board and Committee Changes	Jun. 22	CI
Indian Equities End Higher, Buoyed by Positive Global Cues Due to US Inflation Data	Jun. 13	MT
Indian Equities Close with Mild Gains on Friday, Helped by Financial, Telecom Stocks	May. 31	MT
Indian Equities Dragged Down by Losses in Financial, IT Stocks	May. 29	MT
Indian Equities Extend Losing Run to Third Day Amid Poll Worries	May. 28	MT
INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher	May. 28	RE
INDIA STOCKS-Metal stocks lead Indian shares higher	May. 28	RE
Profit Booking Drags Indian Equities to End with Marginal Losses on Monday	May. 27	MT
Jefferies Adjusts Divi’s Laboratories Price Target to INR4,050 From INR3,610, Keeps at Hold	May. 27	MT
INDIA STOCKS-Indian shares ease off record highs as volatility stays elevated	May. 27	RE
Divi's Laboratories' Consolidated Profit Jumps in Fiscal Q4; Shares Climb 3%	May. 27	MT
INDIA STOCKS-Indian shares at record highs, boosted by pharma stocks, Adani Ports	May. 27	RE
Transcript : Divi's Laboratories Limited, Q4 2024 Earnings Call, May 25, 2024	May. 25
Divi's Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 25	CI
Divi's Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 25	CI
Divi's Laboratories Limited Recommends A Final Dividend for the Financial Year 2023-24	May. 25	CI
Weak March Quarter Earnings Weigh Down Indian Equities on Friday	Apr. 26	MT
Divi's Laboratories Plans Up To INR7 Billion Investment to Boost Capacity	Apr. 25	MT
Indian Equities Close Higher on Friday, Led by Metal, Banking Stocks	Apr. 19	MT
Indian Equities Close Lower on Friday As Hopes for US Rate Cute in June Fade	Apr. 12	MT
Indian Equities End Higher on Wednesday, Lifted Mainly by Metal Stocks	Apr. 10	MT
Divi's Laboratories Limited Approves Appointment of Dr. S. Devendra Rao as Whole-Time Director (Manufacturing)	Apr. 05	CI